Navigation Links
ARMGO Pharma Receives $1 Million Award from MDA to Support Advancement of Rycal Compound ARM210 as a Novel Treatment for Duchenne Muscular Dystrophy
Date:4/17/2013

TARRYTOWN, N.Y. and TUCSON, Ariz., April 17, 2013 /PRNewswire/ -- ARMGO Pharma and the Muscular Dystrophy Association (MDA) today announced that $1 Million has been awarded for preclinical work in support of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for ARM210, a novel, orally available, small-molecule Rycal drug that has potential as a treatment for Duchenne muscular dystrophy (DMD).  The funding award to ARMGO Pharma comes from MDA Venture Philanthropy (MVP), part of MDA's translational research program.

The project being advanced by ARMGO Pharma is focused on a novel class of small molecule drugs known as Rycals™ which target the Ryanodine Receptor (RyR), an intracellular calcium channel that becomes leaky in disease states including muscular dystrophy, contributing to loss of muscle strength and function.  Rycals have been shown in animal models of muscle disease to repair RyR-mediated calcium leak and thereby improve specific muscle force and exercise capacity.  ARMGO Pharma's experimental proprietary drug ARM210 has been selected by the company from its library of Rycal candidates for preclinical advancement as a potential treatment for DMD.  With its unique mechanism of action and oral delivery formulation, ARM210 has the potential to provide benefit across skeletal muscle, diaphragm and heart muscle in DMD patients regardless of genetic background, both as a mono-therapy as well as in conjunction with other treatments.

DMD is one of nine types of muscular dystrophy, a group of genetic, degenerative diseases primarily affecting voluntary muscles.  Caused by mutations in the gene that makes dystrophin, a protein that normally protects muscle cells and keeps th
'/>"/>

SOURCE ARMGO Pharma; Muscular Dystrophy Association
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. VIVUS Announces FDA Approval of Qsymia REMS Modification Allowing Access Through Certified Retail Pharmacies
2. New White Paper Details What Compounding Pharmacies Must Know to Prepare for FDA Inspections
3. Royalty Rates for Pharmaceuticals & Biotechnology: Real-Deal Information for Hundreds of Transactions
4. Omthera Pharmaceuticals, Inc. Announces Closing of Initial Public Offering
5. Avion Pharmaceuticals, LLC., announces further expansion of their Womens Health Sales Team
6. Oramed Pharmaceuticals Appoints New Chief Operating Officer and VP of Business Development
7. Valeant Pharmaceuticals To Announce 2013 First Quarter Results On May 2, 2013
8. CPhI und PharmaEvolution.com werden die Pharmaindustrie in Monats- und Jahresberichten analysieren
9. CPhI et PharmaEvolution.com sapprêtent à analyser lindustrie pharmaceutique dans des rapports mensuels et annuels
10. CPhI y PharmaEvolution.com analizarán la industria farmacéutica con informes mensuales y anuales
11. Distribution on the pharmaceutical market in Poland 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... March 27, 2015 As of February, ... incontinence devices for women. "Shipping thousands ... gratifying part is the hundreds of letters, emails ... lives have been positively impacted by our technology," ... InControl recently released Apex, an over-the-counter ...
(Date:3/27/2015)... DALLAS , March 27, 2015   ... global leader in biosimilars and the world,s leading ... two studies that support an evaluation of biosimilarity ... U.S. Food and Drug Administration (FDA) conditionally approved ... Amgen,s EPOGEN™ (epoetin alfa). These study data were ...
(Date:3/27/2015)... NEW BRUNSWICK, N.J. , March 27, 2015  Johnson ... Meeting of Shareholders at 10 a.m. (Eastern Time) on Thursday, ... New Brunswick, N.J. Investors and other ... meeting by visiting the Company,s website at www.jnj.com ... of presentations from the meeting will be made available a ...
Breaking Medicine Technology:InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3
... , MINNETONKA, Minn., Dec. 1 ... company specializing in clinical study management systems, today ... technology solution, has been certified by the Clinical ... the Operational Data Model (ODM) standard. This ...
... , CAMBRIDGE, Mass. and TOKYO, Dec. 1 Galenea ... further extension of their research and development collaboration through ... to seven years and brings the total committed funding ... working together since January 2005 with the goal of ...
Cached Medicine Technology:MedNet Solutions' ENLIGHTEN Receives CDISC ODM Certification 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 3
(Date:3/27/2015)... Ticket Down is a reputable source of authentic ... Omaha, Nebraska on Friday, May 8th and Saturday, May 9th. ... be added in Omaha as Garth has done in other ... Brooks World Tour is continuing its run throughout the United ... and Trisha Yearwood will bring their act to Omaha, NE ...
(Date:3/27/2015)... March 27, 2015 On March ... with former Detroit Lions wide receiver Herman Moore, ... educational presentation on substance abuse, treatment options and ... who attended were pastors, ministers and bishops from ... other distinguished guests. , “Our ‘Fighting Addiction Together’ ...
(Date:3/27/2015)... USA (PRWEB) March 27, 2015 According ... rates of newborns born with Neonatal Abstinence Syndrome (NAS) ... NAS will undergo the painful withdrawal process for a ... body tremors, excessive crying, diarrhea, and vomiting. The condition ... undergoing drug and alcohol addiction treatment (and employing medically ...
(Date:3/27/2015)... GrassrootsHealth, an international nonprofit public health ... NOW! vitamin D demonstration project April 7 in the ... (MUSC), and will soon follow with a second phase ... to a minimum of 500 pregnant women at 17 ... service areas. The project will include patient and health ...
(Date:3/27/2015)... Operatic contenders and their avid audience ... 17th. The universally acclaimed baritone Sherrill Milnes will be ... Idol at The Merion in Evanston. The event is ... aspiring opera singers from around the country. “This is ... finest young talent in the country,” said Margaret Gergen, ...
Breaking Medicine News(10 mins):Health News:Cheap Garth Brooks Tickets for CenturyLink Center in Omaha: Ticket Down Slashes Garth Brooks Concert Tickets in Omaha, NE at the CenturyLink Center 2Health News:Cheap Garth Brooks Tickets for CenturyLink Center in Omaha: Ticket Down Slashes Garth Brooks Concert Tickets in Omaha, NE at the CenturyLink Center 3Health News:LiveToBeSober.org Hosts Conference on Substance Abuse Treatment and Recovery at Ford Field 2Health News:In Florida Only 10% of Pregnant Mothers Are Referred to Drug Rehab Despite Testing Positive for Narcotics 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 3Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 4Health News:Opera Idol Competition At The Merion In Evanston 2
... in 14 of Indonesia's 33 provinces has killed at least ... health officials said Tuesday//. ,But this month's figure ... when over 18,900 people were infected and the disease claimed ... ,The ministry had taken several measures to reduce the ...
... from Amgen Inc disclosed a rise in number of deaths ... that such drugs should be prescribed in restricted conditions only. ... on the natural protein called erythropoietin (EPO) which augments the ... is the major product of Amgen Inc and has also ...
... the government to bring about new and effective campaigns against ... be main reason for this sudden surge in AIDS cases ... there is a phenomenal 41% increase of HIV cases which ... spend $10 million for campaigns which would address these issues ...
... the extent of neurological ailments in the land of dreams//. ... Deborah Hirtz, and colleagues from the National Institute of Neurological ... treated neurological diseases in the country. , ... years and indexed the diseases according to various factors including ...
... sudden changes in your diet any more because of any ... health sciences, can help you have your own personalised diet ... ,Health expert Dr. Sam Rehnborg, the president of Nutrilite Health ... through the depression of making a sudden change in diet ...
... barely one month in Malaysia this year, a senior health ... said five more dengue fever deaths were reported in Selangor ... total death toll to 13 nationwide. ,In the ... of which 403 have been confirmed as dengue fever. ...
Cached Medicine News:
... safe care environment by automatically bar code printing ... level. The automated process and reliable bar codes ... of all items, including vials, ampules, syringes, IV ... saves valuable time for pharmacy staff and helps ...
wBloodCare™ provides functionality at the bedside to ensure that the correct patient receives the correct blood product....
Specimen-ID™, a Positive Specimen Identification System, assures the permanent link at the bedside between patient and laboratory specimen to prevent sample identification errors....
wCareMed™ utilizes barcode scanning technology to support medication administration. It is a simple to use point of care application that provides access to patient information on a lightweight,...
Medicine Products: